Iron chelators in myelodysplastic syndrome: to lower ferritin levels or to improve survival?
- PMID: 24183304
- DOI: 10.1016/j.leukres.2013.09.016
Iron chelators in myelodysplastic syndrome: to lower ferritin levels or to improve survival?
Comment on
-
A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes.Leuk Res. 2013 Dec;37(12):1612-5. doi: 10.1016/j.leukres.2013.07.021. Epub 2013 Aug 9. Leuk Res. 2013. PMID: 23937987
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical